Carlyle Group Inc. - Q4 2015 holdings

$7.58 Billion is the total value of Carlyle Group Inc.'s 31 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 150.0% .

 Value Shares↓ Weighting
NXPI NewNXP Semiconductors N V$928,954,00011,026,158
+100.0%
12.26%
MPSX NewMulti Packaging Solutions In$466,942,00026,913,072
+100.0%
6.16%
EVA BuyEnviva Partners LP$240,529,000
+56.4%
13,252,299
+7.7%
3.17%
+185.1%
USAC BuyUSA Compression Partners LP$83,504,000
-12.0%
7,267,510
+10.4%
1.10%
+60.4%
MPOYQ NewMidstates Pete Co Inc$5,923,0002,932,341
+100.0%
0.08%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-02-12
  • View 13F-HR/A filed 2016-05-13
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wesco Aircraft Hldgs Inc28Q4 201916.8%
Seacor Marine Hldgs Inc22Q3 20231.1%
Enviva Partners LP21Q2 202031.5%
Enduro Rty Tr21Q1 20182.8%
USA Compression Partners LP20Q2 201828.5%
Pattern Energy Group Inc20Q3 201816.2%
Concord Med Svcs Hldgs Ltd19Q3 20171.1%
Superior Energy Svcs Inc19Q3 20170.7%
Cobalt Intl Energy Inc17Q1 201711.0%
Sequential Brnds Group Inc N17Q1 20201.7%

View Carlyle Group Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Carlyle Group Inc. Q4 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Complete Solaria, Inc.September 22, 20232,745,8795.7%
Carlyle Credit Income FundSeptember 14, 20234,785,62841.0%
Vera Therapeutics, Inc.August 02, 20231,872,7644.2%
Reneo Pharmaceuticals, Inc.May 09, 20232,730,4578.2%
EXICURE, INC.April 13, 2023287,1373.4%
SPRUCE BIOSCIENCES, INC.February 23, 20233,734,5189.2%
Vaxcyte, Inc.February 10, 20232,070,7242.6%
NuCana plcAugust 11, 20223,353,1346.4%
1Life Healthcare IncFebruary 11, 202213,612,6817.1%
Atotech LtdFebruary 11, 2022153,672,70378.9%

View Carlyle Group Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
42024-06-18
42024-06-14
8-K2024-05-31
42024-05-23
42024-05-23
42024-05-23
42024-05-23
42024-05-23
SC 13D/A2024-05-14
SC 13D/A2024-05-13

View Carlyle Group Inc.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been amended

Export Carlyle Group Inc.'s holdings